{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:26:29Z","timestamp":1780633589245,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00066-010-2089-2","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T17:37:41Z","timestamp":1289410661000},"page":"614-620","source":"Crossref","is-referenced-by-count":36,"title":["Total Body Irradiation (TBI) in Pediatric Patients","Ganzk\u00f6rperbestrahlung (TBI) in der P\u00e4diatrie \u2013 30 Jahre Erfahrungen mit Niedrig-Dosisraten-Bestrahlung"],"prefix":"10.1007","volume":"186","author":[{"given":"Claudia","family":"Linsenmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Thoennessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Negretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bourquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Streller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs Martin","family":"L\u00fctolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"2089_CR1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0360-3016(83)90393-0","volume":"9","author":"Barrett","year":"1983","unstructured":"Barrett A, Depledge MH, Powles RL. Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys 1983;9:1029\u201333","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2089_CR2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bmt.1704945","volume":"35","author":"Berger","year":"2005","unstructured":"Berger C, et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 2005;35:991\u20135","journal-title":"Bone Marrow Transplant"},{"key":"2089_CR3","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2005-01-0035","volume":"105","author":"Bhatia","year":"2005","unstructured":"Bhatia S, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 2005;105:4215\u201322","journal-title":"Blood"},{"key":"2089_CR4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2001.19.2.464","volume":"19","author":"Bhatia","year":"2001","unstructured":"Bhatia S, et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001;19:464\u201371","journal-title":"J Clin Oncol"},{"key":"2089_CR5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V79.10.2578.bloodjournal79102578","volume":"79","author":"Blaise","year":"1992","unstructured":"Blaise D, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d\u2019Etudes de la Greffe de Moelle Osseuse. Blood 1992;79:2578\u201382","journal-title":"Blood"},{"key":"2089_CR6","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","volume":"81","author":"Blume","year":"1993","unstructured":"Blume KG, et al. A prospective randomized comparison of total body irradiation- etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood 1993;81: 2187\u201393","journal-title":"Blood"},{"key":"2089_CR7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(82)91633-6","volume":"319","author":"Bortin","year":"1982","unstructured":"Bortin MM, et al. Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet 1982;319: 437\u20139","journal-title":"Lancet"},{"key":"2089_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0167-8140(90)90175-V","volume":"18","author":"Briot","year":"1990","unstructured":"Briot E, Dutreix A, Bridier A. Dosimetry for total body irradiation. Radiother Oncol 1990;18(Suppl 1):16\u201329","journal-title":"Radiother Oncol"},{"key":"2089_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1704549","volume":"34","author":"Bruno","year":"2004","unstructured":"Bruno B, et al. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre. Bone Marrow Transplant 2004;34:143\u20137","journal-title":"Bone Marrow Transplant"},{"key":"2089_CR10","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","volume":"84","author":"Clift","year":"1994","unstructured":"Clift RA, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994;84:2036\u201343","journal-title":"Blood"},{"key":"2089_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0167-8140(90)90179-Z","volume":"18","author":"Cosset","year":"1990","unstructured":"Cosset JM, et al. Clinical basis for TBI fractionation. Radiother Oncol 1990;18(Suppl 1):60\u20137","journal-title":"Radiother Oncol"},{"key":"2089_CR12","first-page":"151","volume":"1","author":"Deeg","year":"1986","unstructured":"Deeg HJ, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986;1:151\u20137","journal-title":"Bone Marrow Transplant"},{"key":"2089_CR13","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V85.8.2263.bloodjournal8582263","volume":"85","author":"Devergie","year":"1995","unstructured":"Devergie A, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM). Blood 1995;85:2263\u20138","journal-title":"Blood"},{"key":"2089_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00066-008-1882-7","volume":"184","author":"Eich","year":"2008","unstructured":"Eich HT, M\u00fcller RP, Engenhart-Cabillic R, et al. Involved-node radiotherapy in early-stage Hodgkin\u2019s lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 2008;184:406\u201310","journal-title":"Strahlenther Onkol"},{"key":"2089_CR15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ijrobp.2005.04.031","volume":"63","author":"Faraci","year":"2005","unstructured":"Faraci M, et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005;63:1568\u201375","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2089_CR16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00066-009-2022-8","volume":"185","author":"Gerstein","year":"2009","unstructured":"Gerstein J, et al. Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT). Strahlenther Onkol 2009;185:751\u20135","journal-title":"Strahlenther Onkol"},{"key":"2089_CR17","first-page":"1060","volume":"85","author":"Granados","year":"2000","unstructured":"Granados E, et al. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation. Haematologica 2000;85:1060\u20137","journal-title":"Haematologica"},{"key":"2089_CR18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00066-006-1528-6","volume":"182","author":"Kal","year":"2006","unstructured":"Kal HB, et al. Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation. Strahlenther Onkol 2006;182: 672\u20139","journal-title":"Strahlenther Onkol"},{"key":"2089_CR19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2003.06.001","volume":"58","author":"Miralbell","year":"2004","unstructured":"Miralbell R, et al. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Int J Radiat Oncol Biol Phys 2004;58: 809\u201316","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2089_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/131.1.243","volume":"131","author":"Peters","year":"1979","unstructured":"Peters LJ, et al. Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation. Radiology 1979;131:243\u20137","journal-title":"Radiology"},{"key":"2089_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00066-009-1007-y","volume":"185","author":"Pommier","year":"2009","unstructured":"Pommier P, et al. Second cancer after total-body irradiation (TBI) in childhood. Strahlenther Onkol 2009; 185(Suppl 2):13\u20136","journal-title":"Strahlenther Onkol"},{"key":"2089_CR22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00066-008-1823-5","volume":"184","author":"Ramm","year":"2008","unstructured":"Ramm U, Licher J, Moog J, et al. In vivo dosimetry with semiconducting diodes for dose verification in total-body irradiation. A 10-year experience. Strahlenther Onkol 2008;184:376\u201380","journal-title":"Strahlenther Onkol"},{"key":"2089_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-009-1008-x","volume":"185","author":"Ricardi","year":"2009","unstructured":"Ricardi U, et al. Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies. Strahlenther Onkol 2009;185(Suppl 2):17\u201320","journal-title":"Strahlenther Onkol"},{"key":"2089_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x","volume":"93","author":"Ringden","year":"1996","unstructured":"Ringden O, et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996;93:637\u201345","journal-title":"Br J Haematol"},{"key":"2089_CR25","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.leu.2403821","volume":"19","author":"Robin","year":"2005","unstructured":"Robin M, et al. A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLAidentical sibling donors. Leukemia 2005;19:1613\u201320","journal-title":"Leukemia"},{"key":"2089_CR26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2005.02.032","volume":"63","author":"Sampath","year":"2005","unstructured":"Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 2005;63:876\u201384","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2089_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2004.12.328","volume":"11","author":"Savani","year":"2005","unstructured":"Savani BN, et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:223\u201330","journal-title":"Biol Blood Marrow Transplant"},{"key":"2089_CR28","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","volume":"98","author":"Socie","year":"2001","unstructured":"Socie G, et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98:3569\u201374","journal-title":"Blood"},{"key":"2089_CR29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.10773","volume":"95","author":"Tauchmanova","year":"2002","unstructured":"Tauchmanova L, et al. High prevalence of endocrine dysfunction in longterm survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002;95:1076\u201384","journal-title":"Cancer"},{"key":"2089_CR30","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/bmt.2008.47","volume":"41","author":"Vettenranta","year":"2008","unstructured":"Vettenranta K. Current European practice in pediatric myeloablative conditioning. Bone Marrow Transplant 2008;41(Suppl 2):S14\u20137","journal-title":"Bone Marrow Transplant"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2089-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T17:53:41Z","timestamp":1592070821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2089-2"}},"subtitle":["A Single-center Experience after 30 Years of Low-dose Rate Irradiation"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["2089"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2089-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}